Peripheral blood phagocyte CD14 and CD11b expression on admission to hospital in relation to mortality among patients with community-acquired infection

Inflammation Research

Volumn 54, Issue 10, 2005, Pages 428-434

  Aalto, H ^a   Takala, A ^a   Kautiainen, H ^b   Repo, H ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Blood culture; CD14; Community acquired infection; Prediction of mortality; Systemic inflammation

Indexed keywords

BIOLOGICAL MARKER; CD11B ANTIGEN; CD14 ANTIGEN; CD18 ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONFIDENCE INTERVAL; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MONOCYTE; MORTALITY; MULTIVARIATE ANALYSIS; PHAGOCYTE; STATISTICAL ANALYSIS; SURVIVAL;

EID: 27744585153     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-005-1374-5     Document Type: Article

References (35)

1. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101: 1481-3.
2. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6.
3. Vedder NB, Harlan JM. Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J Clin Invest 1988; 81: 676-82.
4. Freyer DR, Morganroth ML, Rogers CE, Arnaout MA, Todd RF,3rd. Modulation of surface CD11/CD18 glycoproteins (Mo1, LFA-1, p 150,95) by human mononuclear phagocytes. Clin Immunol Immunopathol 1988; 46: 272-83.
5. Repo H, Harlan JM. Mechanisms and consequences of phagocyte adhesion to endothelium. Ann Med 1999; 31: 156-65.
6. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-3.
7. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-8.
8. Ertel W, Krombach F, Kremer JP et al. Mechanisms of cytokine cascade activation in patients with sepsis: normal cytokine transcription despite reduced CD14 receptor expression. Surgery 1993; 114: 243-50; discussion 250-1.
9. Lin RY, Astiz ME, Saxon JC, Rackow EC. Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest 1993; 104: 847-53.
10. Heinzelmann M, Mercer-Jones M, Cheadle WG, Polk HC,Jr. CD14 expression in injured patients correlates with outcome. Ann Surg 1996; 224: 91-6.
11. Antal-Szalmas P. Evaluation of CD14 in host defence. Eur J Clin Invest 2000; 30: 167-79.
12. Hack CE, De Groot ER, Felt-Bersma RJ et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989; 74: 1704-10.
13. Hack CE, Nuijens JH, Felt-Bersma RJ et al. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med 1989; 86: 20-6.
14. Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med 1991; 91: 23-9.
15. Dofferhoff AS, Bom VJ, de Vries-Hospers HG et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992; 20: 185-92.
16. Gardinali M, Padalino P, Vesconi S et al. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease. Arch Surg 1992; 127: 1219-24.
17. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119: 771-8.
18. Endo S, Inada K, Nakae H et al. Plasma levels of type II phospholipase A2 and cytokines in patients with sepsis. Res Commun Mol Pathol Pharmacol 1995; 90: 413-21.
19. Ruiz M, Ewig S, Marcos MA et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999; 160: 397-405.
20. van Langevelde P, Joop K, van Loon J et al. Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 2000; 31: 1343-8.
21. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351: 1849-59.
22. Roson B, Carratala J, Fernandez-Sabe N, Tubau F, Manresa F, Gudiol F. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med 2004; 164: 502-8.
23. Gluck T, Silver J, Epstein M, Cao P, Farber B, Goyert SM. Parameters influencing membrane CD14 expression and soluble CD14 levels in sepsis. Eur J Med Res 2001; 6: 351-8.
24. de Werra I, Zanetti G, Jaccard C et al. CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumonia. Swiss Med Wkly 2001; 131: 35-40.
25. Kylanpaa-Back ML, Takala A, Kemppainen E et al. Cellular markers of systemic inflammation and immune suppression in patients with organ failure due to severe acute pancreatitis. Scand J Gastroenterol 2001; 36: 1100-7.
26. Takala A, Nupponen I, Kylanpaa-Back ML, Repo H. Markers of inflammation in sepsis. Ann Med 2002; 34: 614-23.
27. Tschaikowsky K, Hedwig-Geissing M, Schiele A, Bremer F, Schywalsky M, Schuttler J. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 2002; 30: 1015-23.
28. Mentula P, Kylanpaa ML, Kemppainen E et al. Plasma anti-inflammatory cytokines and monocyte human leucocyte antigen-DR expression in patients with acute pancreatitis. Scand J Gastroenterol 2004; 39: 178-87.
29. Docke WD, Randow F, Syrbe U et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997; 3: 678-81.
30. Takala A, Jousela I, Jansson SE et al. Markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin Sci (Lond) 1999; 97: 529-38.
31. Chishti AD, Shenton BK, Kirby JA, Baudouin SV. Neutrophil chemotaxis and receptor expression in clinical septic shock. Intensive Care Med 2004; 30: 605-11.
32. Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH. C-reactive protein. A clinical marker in community-acquired pneumonia. Chest 1995; 108: 1288-91.
33. Groeneveld AB, Tacx AN, Bossink AW, van Mierlo GJ, Hack CE. Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection. Clin Immunol 2003; 106: 106-15.
34. Bossink AW, Groeneveld J, Hack CE, Thijs LG. Prediction of mortality in febrile medical patients: How useful are systemic inflammatory response syndrome and sepsis criteria?. Chest 1998; 113: 1533-41.
35. Esel D, Doganay M, Alp E, Sumerkan B. Prospective evaluation of blood cultures in a Turkish university hospital: epidemiology, microbiology and patient outcome. Clin Microbiol Infect 2003; 9: 1038-44.